Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;190(2):849-850.
doi: 10.1007/s11845-020-02346-9. Epub 2020 Aug 18.

Psychoactive compounds as multifactorial protection factors against COVID-19

Hervé Javelot  1   2 , Luisa Weiner  3   4 , Julien Petrignet  5 , Guillaume Meyer  6   7 , Jeanne Briet  8 , Wissam El-Hage  9   10 , Coraline Hingray  11   12
Affiliations
Comment

Psychoactive compounds as multifactorial protection factors against COVID-19

Hervé Javelot et al. Ir J Med Sci. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment on

References

    1. Villoutreix BO, Beaune PH, Tamouza R, Krishnamoorthy R, Leboyer M. Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders. Drug Discov Today. 2020;S1359–6446(20):30250–30256. doi: 10.1016/j.drudis.2020.06.022. - DOI - PMC - PubMed
    1. Plaze M, Attali A, Petit AC, et al. Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study. Encephale. 2020;46(3S):S35–S39. doi: 10.1016/j.encep.2020.04.010. - DOI - PMC - PubMed
    1. Psychiatry SE, COVID-19: the role of chlorpromazine [published online ahead of print Jun 15. Can J Psychiatr. 2020;2020:706743720934997. doi: 10.1177/0706743720934997. - DOI
    1. Briet J, Javelot H, Heitzmann E, Weiner L, Lameira C, D’Athis P, Corneloup M, Vailleau JL. The anticholinergic impregnation scale: towards the elaboration of a scale adapted to prescriptions in French psychiatric settings. Therapie. 2017;72(4):427–437. doi: 10.1016/j.therap.2016.12.010. - DOI - PubMed
    1. Farsalinos K, Niaura R, Le Houeze J, et al. Editorial: nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep. 2020;7:658–663. doi: 10.1016/j.toxrep.2020.04.012. - DOI - PMC - PubMed

Substances